TITUSVILLE, N.J., May 29, 2012 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S.

TITUSVILLE, N.J., April 24, 2012 /PRNewswire/ -- It lies within the compact folded rectangle that accompanies prescription medicines.

TITUSVILLE, N.J., March 27, 2012 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S.

Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen -- marking a major step for Siemens (NYSE: SI) into this important and fast-growing segment of the in vitro diagnostics (IVD) market. Both partnerships intend to leverage the clinical trial and commercialization options within Siemens' CLIA laboratory, as well as Siemens' established IVD clinical and regulatory expertise.

New Approach Intended to Remove Barriers to Innovation in Drug Development WASHINGTON, Feb.